HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxidation of reduced cytosolic nicotinamide adenine dinucleotide by the malate-aspartate shuttle in the K-562 human leukemia cell line.

Abstract
The activity of the malate-aspartate shuttle for the reoxidation of reduced cytosolic nicotinamide adenine dinucleotide (NADH) by mitochondria was studied in a line of human myeloid leukemia cells (K-562). The tumor cells showed mitochondrial reoxidation of cytosolic NADH, as evidenced by the accumulation of pyruvate, when incubated aerobically with L-lactate. The involvement of the respiratory chain in the reoxidation of cytosolic NADH was demonstrated by the action of rotenone, antimycin A, and oligomycin which strongly inhibited the formation of pyruvate from added L-lactate. Moreover, pyruvate production was greatly inhibited by the transaminase inhibitor, aminooxyacetate. Under glycolytic conditions, in the presence of aminooxyacetate, the rate of pyruvate production was also markedly inhibited, the rate of lactate accumulation was stimulated, and at 60 min the cytosolic NADH/nicotinamide adenine dinucleotide (NAD) ratio had increased progressively about 5-fold with respect to untreated cells. The maximal rate of the malate-aspartate shuttle has also been established by addition of arsenite to inhibit mitochondrial oxidation of the pyruvate formed from added L-lactate.
AuthorsL López-Alarcón, M L Eboli
JournalCancer research (Cancer Res) Vol. 46 Issue 11 Pg. 5589-91 (Nov 1986) ISSN: 0008-5472 [Print] United States
PMID3756905 (Publication Type: Journal Article)
Chemical References
  • Arsenites
  • Lactates
  • Malates
  • Pyruvates
  • NAD
  • Aminooxyacetic Acid
  • Aspartic Acid
  • Aspartate Aminotransferases
  • arsenite
  • Arsenic
Topics
  • Aminooxyacetic Acid (pharmacology)
  • Arsenic (pharmacology)
  • Arsenites
  • Aspartate Aminotransferases (antagonists & inhibitors)
  • Aspartic Acid (metabolism)
  • Cells, Cultured
  • Electron Transport (drug effects)
  • Humans
  • Lactates (metabolism)
  • Leukemia, Experimental (metabolism)
  • Malates (metabolism)
  • Mitochondria (metabolism)
  • NAD (metabolism)
  • Oxidation-Reduction
  • Pyruvates (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: